ArticleJournal of the American Heart Association2019

Intravascular Stem Cell Bioreactor for Prevention of Adverse Remodeling After Myocardial Infarction.

Peter V Johnston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.